The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 243 results:
Author [ Title(Desc)] Type Year
Filters: Author is Karagiannis, Asterios  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
Romiopoulos, I., Pyrpasopoulou A., Varouktsi A., Simoulidou E., Kontopoulou K., Karantani E., et al. (2016).  A Rare Case of Disseminated Pyogenic Gonococcal Infection in an Immunocompetent Woman.. Case Rep Infect Dis. 2016, 9629761.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2014).  Reaching hypertriglyceridemia goals.. Curr Med Res Opin. 30(3), 391-3.
Athyros, V. G., Karagiannis A., Katsiki N., & Mikhailidis D. P. (2012).  Relation of improvement in glomerular filtration rate with atorvastatin to reductions in heart failure morbidity.. Am J Cardiol. 110(5), 763.
Doumas, M., Stavropoulos K., Imprialos K. P., Athyros V. G., & Karagiannis A. (2018).  Renal sympathetic denervation: Ashes to ashes or rebirth from the ashes?. J Clin Hypertens (Greenwich). 20(4), 634-636.
Boutari, C., Georgianou E., Sachinidis A., Katsimardou A., Christou K., Piperidou A., et al. (2019).  Renovascular Hypertension: Novel Insights:. Current Hypertension Reviews. 15,
Boutari, C., Georgianou E., Sachinidis A., Katsimardou A., Christou K., Piperidou A., et al. (2020).  Renovascular Hypertension: Novel Insights.. Curr Hypertens Rev. 16(1), 24-29.
Pagourelias, E. D., Gossios T. D., Tziomalos K., Karagiannis A., Geleris P., & Athyros V. G. (2011).  Residual cardiac risk reduction beyond lipid lowering.. Hellenic J Cardiol. 52(3), 197-203.
Kargiotis, K., Athyros V. G., Giouleme O., Katsiki N., Katsiki E., Anagnostis P., et al. (2015).  Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome.. World J Gastroenterol. 21(25), 7860-8.
Athyros, V. G., Karagiannis A., Katsiki N., & Mikhailidis D. P. (2012).  Response to 'Mildly decreased glomerular filtration rate is associated with poor coronary heart disease outcome'.. Clin Cardiol. 35(5), 315; author reply 316-7.
Koutsampasopoulos, K., Vogiatzis I., Ziakas A., Papadopoulos C., Imprialos K. P., Stavropoulos K., et al. (2019).  Right Ventricular Function and Sexual Function: Exploring Shadows in Male and Female Patients With Heart Failure.. J Sex Med.
Tziomalos, K., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2010).  The role of ankle brachial index and carotid intima-media thickness in vascular risk stratification.. Curr Opin Cardiol. 25(4), 394-8.
Kakafika, A. I., Mikhailidis D. P., Karagiannis A., & Athyros V. G. (2007).  The role of endocannabinoid system blockade in the treatment of the metabolic syndrome.. J Clin Pharmacol. 47(5), 642-52.
Karagiannis, A., Mikhailidis D. P., Athyros V. G., Kakafika A. I., Tziomalos K., Liberopoulos E. N., et al. (2007).  The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?. Expert Opin Ther Targets. 11(2), 191-205.
Tziomalos, K., Kakafika A. I., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2009).  The role of statins for the primary and secondary prevention of coronary heart disease in women.. Curr Pharm Des. 15(10), 1054-62.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2014).  The role of statins in the treatment of type 2 diabetes mellitus: an update.. Curr Pharm Des. 20(22), 3665-74.
S
Athyros, V. G., Tziomalos K., Gossios T. D., Griva T., Anagnostis P., Kargiotis K., et al. (2010).  Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis.. Lancet. 376(9756), 1916-22.
Athyros, V. G., Giouleme O., Ganotakis E. S., Elisaf M., Tziomalos K., Vassiliadis T., et al. (2011).  Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study.. Arch Med Sci. 7(5), 796-805.
Karagiannis, A., Tziomalos K., Mikhailidis D. P., Semertzidis P., Kountana E., Kakafika A. I., et al. (2010).  Seasonal variation in the occurrence of stroke in Northern Greece: a 10 year study in 8204 patients.. Neurol Res. 32(3), 326-31.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2017).  Semaglutide, lipid-lowering drugs, and NAFLD.. Lancet Diabetes Endocrinol. 5(5), 329-330.
Karagiannis, A., Mikhailidis D. P., Tziomalos K., Sileli M., Savvatianos S., Kakafika A., et al. (2007).  Serum uric acid as an independent predictor of early death after acute stroke.. Circ J. 71(7), 1120-7.
Imprialos, K., Faselis C., Boutari C., Stavropoulos K., Athyros V., Karagiannis A., et al. (2017).  SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature.. Curr Pharm Des. 23(10), 1510-1521.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2015).  Short-, mid-, and long-term benefits of peri-procedural high-intensity statin administration in patients undergoing percutaneous coronary intervention.. Curr Med Res Opin. 31(2), 191-5.
Athyros, V. G., Tziomalos K., Karagiannis A., Anagnostis P., & Mikhailidis D. P. (2010).  Should adipokines be considered in the choice of the treatment of obesity-related health problems?. Curr Drug Targets. 11(1), 122-35.
Karagiannis, A., Athyros V. G., Papageorgiou A., Tziomalos K., & Elisaf M. (2006).  Should atenolol still be recommended as first-line therapy for primary hypertension?. Hellenic J Cardiol. 47(5), 298-307.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2012).  Should raising high-density lipoprotein cholesterol be a matter of debate?. J Cardiovasc Med (Hagerstown). 13(4), 254-9.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.